Novel inhibitors and activity-based probes targeting serine proteases. (2022)
Attributed to:
Application of drug delivery technologies to enhance translational of experimental therapeutics
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fchem.2022.1006618
PubMed Identifier: 36247662
Publication URI: http://europepmc.org/abstract/MED/36247662
Type: Journal Article/Review
Volume: 10
Parent Publication: Frontiers in chemistry
ISSN: 2296-2646